Cobro Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
BiotechAndover, US
Drew Dennison(Chief Executive Officer)Bobby Sandage(Director)Carl Novina(Director)Jeffrey Wagner(Chief Scientific Officer)Tom Erickson(Director)Julia A. Novina(Chief Legal Officer)
Board seatTodd Kaloudis· per SEC Form D · $13.9M raise · filed May 2022
BiotechCambridge, US
Carl Novina(Director)Elena Prokupets(Director)Barry Polisky(Director)Andrea Armstrong(Director)Dominique Verhelle(Director)Marc A. Cohen(Executive Officer, Director)
Board seatArthur Becker· per SEC Form D · $50M raise · filed Jan 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.